Back to Search Start Over

Growth factor-induced contraction of human bronchial smooth muscle is Rho-kinase-dependent

Authors :
Mechteld M. Grootte Bromhaar
S. Adriaan Nelemans
Herman Meurs
Bart Vrugt
Johan Zaagsma
Dedmer Schaafsma
Reinoud Gosens
Groningen Research Institute for Asthma and COPD (GRIAC)
Molecular Pharmacology
Faculty of Science and Engineering
Source :
European Journal of Pharmacology, 494(1), 73-76. ELSEVIER SCIENCE BV
Publication Year :
2004
Publisher :
Elsevier BV, 2004.

Abstract

Growth factors have been implicated in the pathophysiology of asthma. However, the putative effects of these growth factors on human airway smooth muscle tone are still largely unknown. We performed contraction experiments using human bronchial smooth muscle ring preparations. The growth factor insulin-like growth factor-1 (IGF-1) induced a slowly developing sustained contraction, which was dependent on Rho-kinase, since contraction was almost completely inhibited by (+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl) cyclohexane carboxamide (Y-27632; 1 muM). Angiotensin II, a G(q)-coupled receptor agonist which can act as a growth factor as well, induced a biphasic contraction, the sustained phase of which was also almost completely inhibited by Y-27632. We conclude that angiotensin II and IGF-1 induce a Rho-kinase-dependent sustained contraction of human bronchial smooth muscle. Since growth factors are associated with pathophysiologiocal conditions such as asthma, inhibition of Rho-kinase could be effective under these conditions. (C) 2004 Elsevier B.V. All rights reserved.

Details

ISSN :
00142999
Volume :
494
Database :
OpenAIRE
Journal :
European Journal of Pharmacology
Accession number :
edsair.doi.dedup.....fb5c4808fdc2f623cac1116389383c90
Full Text :
https://doi.org/10.1016/j.ejphar.2004.04.035